Comprehensive Cancer Center
We are responsible for oncological treatment of cancer (other than surgical treatment) and hematology, i.e. treatment of blood disorders, breast surgery, and radiation therapy services in the Uusimaa region. We also treat patients arriving from across Finland requiring specialist medical care. The Comprehensive Cancer Center is one of the 13 departments in the Helsinki University Hospital Area.
The Comprehensive Cancer Center is Finland's largest and most versatile cancer treatment center. We provide personalized treatment, the quality of which is guaranteed by the personnel’s high level of competence and our modern state-of-the-art technology.
The Comprehensive Cancer Center is the first Nordic cancer center to have undergone OECI accreditation and achieved the highest possible status of a Comprehensive Cancer Center. Our expertise is internationally highly valued and our treatment results are world-class.
Our customer panels and experts by experience bring an important patient perspective to the development of our operations.
The key objective of our research activities is to promote translation, i.e. faster and more efficient utilization of the research results for the benefit of the patient. At the center, we also carry out phase I studies and first-in-man trials.
We are responsible for non-surgical treatment of cancers in the Uusimaa region.
We are responsible for the examination, diagnosis and treatment of acute and severe hematological diseases. Treatments for malignant blood disorders have improved remarkably in recent years, and today most patients can be cured with cytostatic therapy or stem cell transplantations.
Our Hematology Outpatient Clinic also has a Coagulation Disorder Unit where we diagnose and treat patients with occlusions or hemorrhage. In addition, we have a national special responsibility for bone marrow transplantations (allogeneic stem cell transplantation).
In breast surgery, we are responsible for surgical treatment of breast cancer and other breast tumors, corrective breast surgery and breast reduction surgery, and surgery for inflammatory changes in breasts. With more than 1,600 breast surgeries performed each year, we are the field’s largest operator in the Nordic countries. Approximately 90% of the breast cancer patients we treat are alive five years after diagnosis.
We are responsible for radiation therapy in the Uusimaa region. We are Finland's largest unit providing radiation therapy. The radiation therapy methods at our disposal are the most versatile in Finland. We treat 4,300 patients every year and more than 300 patients every day.
The clinical trial unit studies cancer treatments that usually are not yet publicly available. The research target may be a new cancer medicine that has not yet been granted market authorization.
Our unit performs international cancer medicine research in phases I through IV, and treats all types of cancer. The treatments are demanding trial treatments that include cytotoxic drug treatment, immunological, antibody, and viral treatments, as well as radiotherapy.